Drugs / GoldenExo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07693036 | Jun 2026 → Jun 2028 expected | type 2 diabetes mellitus | Peking University First Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GoldenExo | “GoldenExo（NATX） treatment group” NCT07693036 ↗ |
| Known as | NATX | “GoldenExo（NATX） treatment group” NCT07693036 ↗ |
| Route | Intravenous | “intravenous infusions once weekly for 8 weeks” NCT07693036 ↗ |